Stem Cell Assurance Announces a Financing and Marketing Partnership With MDwerks

Name	Symbol	Market	Type
Swan Enhanced Dividend Income ETF	AMEX:SCLZ	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

Swan Enhanced Dividend Income ETF

AMEX:SCLZ

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.008	0.02%	51.1712	51.1632	51.1632	51.1632	0	21:15:00

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

0.008

0.02%

51.1712

51.1632

21:15:00

Stem Cell Assurance Announces a Financing and Marketing Partnership With MDwerks

21/01/2010 2:30pm

PR Newswire (US)

Swan Enhanced Dividend I... (AMEX:SCLZ)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Swan Enhanced Dividend I... Charts.

BOCA RATON, Fla., Jan. 21 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (PK: SCLZ) and MDwerks, Inc. (OTC:MDWK) (BULLETIN BOARD: MDWK) announced today a financing and marketing partnership today wherein MDwerks, through it's Xeni Finance subsidiary, has provided the first tranche of financing to Stem Cell for the purchase of various medical devices from Cytori Therapeutics, Inc. In addition, MDwerks, through its subsidiary Digital Pen Applications, Inc. (DPA), will assist in marketing Stem Cell products and services to the health care and medical community initially in Florida. Stem Cell also has expansion plans for New York, New Jersey, Texas and California. Stem Cell is a science based adult stem cell company that provides private stem cell collection, storage, treatment and preservation services. Storage (banking) preserves the age of stem cells and, therefore their potency and allows the individual to preserve their stem cells when they are healthy and later have access to them when needed. This also allows the patient's doctor to access the stem cells on multiple occasions if needed for more than one treatment. The regenerative cell technique promotes tissue survival, graft retention, and increased volume, making it more effective than traditional procedures. The use of the regenerative cells in the graft enables transplanted fat to successfully integrate with the surrounding tissue much better than with previous methods. DPA also specializes in the sale, leasing and maintenance of digital pens, related software and management systems that will create Electronic Medical Records (EMR's) and provides cost-effective data entry solutions using the digital pen process to eliminate the effort and expense of re-entering information already written on existing business documents. The Digital Pen Process can be easily customized and integrated into almost any IT system and automates the conversion of handwritten information into electronic data, resulting in immediate automated full image capture, time stamped point-of-service records and electronic image storage and retrieval that will satisfy legal and regulatory document retention requirements. DPA can supply solutions for almost any business field that relies heavily on handwritten forms including nursing homes, transportation, long-term care facilities, ambulance services, shipping and warehousing. Contacts: Richard Proodian, CFO David M. Barnes, CEO Stem Cell Assurance, Inc. MDwerks, Inc. 561-362-4142 954-389-8300 http://www.stemcallassurance.com/ http://www.mdwerks.com/ DATASOURCE: Stem Cell Assurance, Inc. CONTACT: Richard Proodian, CFO, Stem Cell Assurance, Inc., +1-561-362-4142, or David M. Barnes, CEO, MDwerks, Inc., +1-954-389-8300 Web Site: http://www.stemcellassurance.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SCLZ Swan Enhanced Dividend Income ETF